Comparison of ¹¹¹In Leakage from Labeled Endocardial and Epicardial Cells: Impact on Modeling Viability of Cells to Be Transplanted into Myocardium

Table 1

Heart to wholebody ratios of ¹¹¹In postinjection (ratios expressed as %).

EPI (%)
Dog	1	2	3	4	5	6	7	8	9
0 hrs	31.8	19.4	45.3*	49.2	62.6	56.4	59.7	57.8	49.5
⋮	29.4	18.3	—	47.6	60.5	53.6	56.9		45.1
⋮			—	46.8			55.0	54.1	42.9
⋮	27.9	17.4	—	46.3	59.2	52.5	54.2
⋮			—	46.2	57.2			51.4	41.0
5 hrs	26.3	17.1	—	45.5	56.4	51.2	52.5	49.3	39.4
ENDO (%)
Dog	1	2	3	4	5	6	7	8	9	10
0 hrs	22.8	42.9	45.5	44.0	54.1	62.5	60.0	49.2	59.8	57.6
⋮	23.9	40.8	43.2	42.3	52.0	60.3	56.1	47.6	54.4	54.8
⋮	21.3	39.0	40.6	40.9	50.1	59.5	54.0	44.7	50.5	52.5
⋮	20.6	37.9	38.9		48.5	58.4	52.3	43.0	47.2	50.2
⋮	19.9	36.9	37.5	40.1	47.7	57.6	51.4	41.6	44.5	48.4
5 hrs	19.1	36.3	36.8	39.4	46.7	—	—	—	—	—

*Serial wholebody scans not acquired at day 0.
All data acquired over a 5 hr period following injection.